US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

3.02

-0.2800-8.48%

Pre-market: 3.020.00000.00%08:29 EDT

Volume:1.75M

Turnover:5.33M

Market Cap:164.30M

PE:-0.36

High:3.30

Open:3.30

Low:2.98

Close:3.30

Loading ...

Overview Company News Filings

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires Live

Alumis, Acelyrin Shareholders Approve Merger Deal

MT Newswires Live

BRIEF-Alumis Stockholders Approve Merger With Acelyrin

Acelyrin Stockholders Approve Merger with Alumis to Form Biopharma Company Focused on Immune-mediated Diseases

Alumis Stockholders Approve Merger With ACELYRIN

THOMSON REUTERS

Alumis Inc - Merger Expected to Close in Q2 2025

THOMSON REUTERS

Foresite Labs Reports Acquisition of Common Shares of Alumis Inc

Acelyrin urges stockholders to vote for proposed merger with Alumis

Acelyrin Inc. Urges Stockholders to Vote for Value-Maximizing Merger with Alumis Ahead of Special Meeting

Press Release: ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis

Alumis Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition

Alumis price target lowered to $14 from $15 at H.C. Wainwright

BRIEF-Alumis And Acelyrin Announce Amended Merger Agreement

Alumis Raises Share Consideration for Acelyrin Acquisition

MT Newswires Live

ACELYRIN, INC. Amends Merger Agreement with Alumis

Alumis Inc - Expects Runway to Fund Operations Into 2027

THOMSON REUTERS

Alumis and ACELYRIN Announce Amended Merger Agreement

THOMSON REUTERS

Alumis Inc - ACELYRIN Stockholders to Receive 0.4814 Shares of Alumis per Share

THOMSON REUTERS

Press Release: Alumis and ACELYRIN Announce Amended Merger Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":3.02,"timestamp":1751054400000,"preClose":3.3,"halted":0,"volume":1749137,"hourTrading":{"tag":"盘前","latestPrice":3.02,"preClose":3.02,"latestTime":"08:29 EDT","volume":596,"amount":1838.1826039999999,"timestamp":1751286545526},"delay":0,"floatShares":8664240,"shares":54405544,"eps":-8.309579,"marketStatus":"Pre-Mkt","change":-0.28,"latestTime":"06-30 08:30:47 EDT","open":3.3,"high":3.3,"low":2.98,"amount":5328272.554028,"amplitude":0.09697,"askPrice":3.45,"askSize":100,"bidPrice":3.02,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.309579,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1751290200000},"marketStatusCode":1,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":3.02,"preHourTrading":{"tag":"盘前","latestPrice":3.02,"preClose":3.02,"latestTime":"08:29 EDT","volume":596,"amount":1838.1826039999999,"timestamp":1751286545526},"postHourTrading":{"tag":"盘后","latestPrice":3.07,"preClose":3.02,"latestTime":"17:51 EDT","volume":249620,"amount":753913.7593,"timestamp":1751061115257},"volumeRatio":1.5611317833850968,"impliedVol":2.4275,"impliedVolPercentile":0.6909},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":8664240,"roa":"-101.07%","roe":"-247.05%","lyrEps":-10.381567,"volumeRatio":1.5611317833850968,"shares":54405544,"dividePrice":0,"high":3.3,"amplitude":0.09697,"preClose":3.3,"low":2.98,"week52Low":2.7601,"pbRate":"0.98","psRate":"9.45","week52High":13.53,"institutionHeld":0,"latestPrice":3.02,"eps":-8.309579,"divideRate":0,"volume":1749137,"delay":0,"ttmEps":-8.309579,"open":3.3,"prevYearClose":7.86,"prevWeekClose":3.02,"prevMonthClose":3.5,"prevQuarterClose":6.14,"fiveDayClose":2.86,"twentyDayClose":3.91,"sixtyDayClose":7.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535882090","title":"Sector Update: Health Care Stocks Decline Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2535882090","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535882090?lang=en_us&edition=fundamental","pubTime":"2025-05-14 02:05","pubTimestamp":1747159552,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Tuesday afternoon, with the NYSE Health Care Index falling 2.6% and the Health Care Select Sector SPDR Fund  dropping 2.3%.The iShares Biotechnology ETF  shed 1.5%.In corporate news, UnitedHealth  suspended its full-year outlook amid higher-than-expected medical costs, while Andrew Witty stepped down as chief executive due to \"personal reasons.\" UnitedHealth shares fell more than 16%.Alumis  shares fell past 8%. Shareholders of Alumis andAcelyrin  separately approved their merger deal at  special meetings. Acelyrin shares also fell over 9%.CNS Pharmaceuticals  shares jumped 35% after the company said it has acquired from Cortice Biosciences an orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UNH","IE00B775H168.HKD","IE00BZ1G4Q59.USD","LU1003077747.HKD","XLV","IE00BKVL7J92.USD","IE00BWXC8680.SGD","IE0004445239.USD","LU0079474960.USD","CNSP","SLRN","LU2279689827.SGD","BK4534","LU0251132253.USD","LU0234572021.USD","BK4154","LU1914381329.SGD","LU2491050071.SGD","LU1670628061.USD","LU0689472784.USD","LU1261432733.SGD","IE00B19Z3B42.SGD","LU0528227936.USD","LU1778281490.HKD","LU0097036916.USD","LU0708995401.HKD","LU0029864427.USD","LU1720051108.HKD","LU0289739699.SGD","ALMS","LU0211328371.USD","IE00B1XK9C88.USD","BK4581","IBB","IE00BFSS8Q28.SGD","IE00B4JS1V06.HKD","LU0820561909.HKD","LU1854103824.USD","IE00B19Z9Z06.USD","BK4533","LU0738911758.USD","IE00BJT1NW94.SGD","LU1153585028.USD","LU0456855351.SGD","LU1037948541.HKD","LU1069347547.HKD","LU0058720904.USD","LU0109391861.USD","LU2028103732.USD","LU0320765059.SGD"],"gpt_icon":1},{"id":"2535970033","title":"Alumis, Acelyrin Shareholders Approve Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2535970033","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535970033?lang=en_us&edition=fundamental","pubTime":"2025-05-14 01:22","pubTimestamp":1747156969,"startTime":"0","endTime":"0","summary":"Alumis  said Tuesday its shareholders approved its pending merger with Acelyrin  at a special shareholder meeting.Separately, Acelyrin also said its stockholders approved its merger agreement with Alumis at a special meeting. Acelyrin stockholders will receive 0.4814 shares of Alumis stock for each Acelyrin share.They expect to close the merger in the second quarter.Price: 4.83, Change: -0.42, Percent Change: -8.00","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","SLRN","BK4139","ALMS"],"gpt_icon":0},{"id":"2535707818","title":"BRIEF-Alumis Stockholders Approve Merger With Acelyrin","url":"https://stock-news.laohu8.com/highlight/detail?id=2535707818","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535707818?lang=en_us&edition=fundamental","pubTime":"2025-05-14 01:05","pubTimestamp":1747155924,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Stockholders Approve Merger With AcelyrinMay 13 (Reuters) - Alumis Inc ALMS.O:ALUMIS STOCKHOLDERS APPROVE MERGER WITH ACELYRINALUMIS INC - MERGER EXPECTED TO CLOSE IN Q2 2025Source text: ID:nGNXbDPfFWFurther company coverage: ALMS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8N9TNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4139","SLRN","BK4007"],"gpt_icon":0},{"id":"2535702774","title":"Acelyrin Stockholders Approve Merger with Alumis to Form Biopharma Company Focused on Immune-mediated Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2535702774","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535702774?lang=en_us&edition=fundamental","pubTime":"2025-05-14 01:00","pubTimestamp":1747155612,"startTime":"0","endTime":"0","summary":"LOS ANGELES, May 13, 2025  -- ACELYRIN, Inc. , a late-stage clinical biopharma company, announced that its stockholders have approved the merger with Alumis Inc. . At a special meeting held today, ACELYRIN stockholders voted in favor of the merger agreement, which stipulates that they will receive 0.4814 shares of Alumis common stock for each share of ACELYRIN common stock owned at the closing of the transaction. The merger aims to create a biopharma company dedicated to developing and commercializing transformative therapies for immune-mediated diseases. The transaction is expected to be completed in the second quarter of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acelyrin Inc. published the original content used to generate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDLvGnWr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","NDAQ","BK4139","BK4007","LU2210149790.SGD","BK4112","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BKPKM429.USD","ALMS","LU2095319765.USD","SLRN","IE00B64PRP62.GBP","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2535702446","title":"Alumis Stockholders Approve Merger With ACELYRIN","url":"https://stock-news.laohu8.com/highlight/detail?id=2535702446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535702446?lang=en_us&edition=fundamental","pubTime":"2025-05-14 01:00","pubTimestamp":1747155600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8N9TNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","SLRN","BK4007","BK4139"],"gpt_icon":0},{"id":"2535170272","title":"Alumis Inc - Merger Expected to Close in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2535170272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535170272?lang=en_us&edition=fundamental","pubTime":"2025-05-14 01:00","pubTimestamp":1747155600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8N9TNF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLRN","BK4139","BK4007","ALMS"],"gpt_icon":0},{"id":"2533102617","title":"Foresite Labs Reports Acquisition of Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2533102617","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533102617?lang=en_us&edition=fundamental","pubTime":"2025-05-07 09:56","pubTimestamp":1746583001,"startTime":"0","endTime":"0","summary":"Foresite Labs, LLC, along with Foresite Labs Affiliates 2021, LLC, reported an acquisition of common shares of Alumis Inc. The filing indicates that these entities are among the beneficial owners, with other reporting beneficial owners also involved. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nNDL1jMxGb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2532886742","title":"Acelyrin urges stockholders to vote for proposed merger with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2532886742","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532886742?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:45","pubTimestamp":1746121551,"startTime":"0","endTime":"0","summary":"ACELYRIN (SLRN) reiterated its confidence that the proposed combination with Alumis (ALMS) is the best path forward and the most value-maximizing o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acelyrin-urges-stockholders-to-vote-for-proposed-merger-with-alumis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acelyrin-urges-stockholders-to-vote-for-proposed-merger-with-alumis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4139","SLRN","BK4007"],"gpt_icon":0},{"id":"2532327886","title":"Acelyrin Inc. Urges Stockholders to Vote for Value-Maximizing Merger with Alumis Ahead of Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2532327886","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532327886?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:30","pubTimestamp":1746120616,"startTime":"0","endTime":"0","summary":"ACELYRIN, Inc. has announced its confidence in a proposed merger with Alumis Inc., scheduled for a stockholder vote on May 13, 2025. The merger aims to create a leading clinical-stage immunology company with a diversified portfolio of product candidates. ACELYRIN's Board of Directors emphasizes that the merger represents the culmination of a comprehensive and competitive process designed to maximize value for all stockholders. ACELYRIN stockholders are expected to retain approximately 48% ownership in the combined company, providing them with significant potential upside. The Board encourages stockholders to focus on the long-term benefits of the merger.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acelyrin Inc. published the origina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL7fZyRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4112","BK4588","IE00BGHQF748.EUR","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","ALMS","IE00BKPKM429.USD","SLRN","BK4007","LU2095319765.USD"],"gpt_icon":0},{"id":"2532859188","title":"Press Release: ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2532859188","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532859188?lang=en_us&edition=fundamental","pubTime":"2025-05-02 01:30","pubTimestamp":1746120600,"startTime":"0","endTime":"0","summary":"Special Meeting of stockholders to vote on the transaction scheduled for May 13, 2025. Reminds stockholders to vote today FOR the proposed merger. LOS ANGELES, May 01, 2025  -- ACELYRIN, Inc. , a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today reiterated its confidence that the proposed combination with Alumis Inc.  is the best path forward and the most value-maximizing outcome for all ACELYRIN stockholders.Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the independent transaction committee , said, \"The ACELYRIN Board and management team are confident that the proposed merger with Alumis represents the most value-maximizing path forward for our company's stockholders. The agreement with Alumis follows a comprehensive and competitive process facilitated by the ACELYRIN Board. Furthermore, it reflects successful efforts by our Board to negotiate a revised agreement with a mea","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2531870530","title":"Alumis Price Target Maintained With a $14.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2531870530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531870530?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:46","pubTimestamp":1746009960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2025 06:46 ET (10:46 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2531082381","title":"Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2531082381","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531082381?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:16","pubTimestamp":1746008177,"startTime":"0","endTime":"0","summary":"In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price targ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/confident-outlook-on-acelyrin-alumis-merger-amid-shareholder-opposition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/confident-outlook-on-acelyrin-alumis-merger-amid-shareholder-opposition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2529373586","title":"Alumis price target lowered to $14 from $15 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2529373586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529373586?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:12","pubTimestamp":1745316772,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Alumis (ALMS) to $14 from $15 and keeps a Buy rating on the shares. The firm cites incremental d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-14-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-lowered-to-14-from-15-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"gpt_icon":0},{"id":"2529870756","title":"BRIEF-Alumis And Acelyrin Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529870756","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529870756?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:53","pubTimestamp":1745236410,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis And Acelyrin Announce Amended Merger AgreementApril 21 (Reuters) - Alumis Inc ALMS.O:ALUMIS AND ACELYRIN ANNOUNCE AMENDED MERGER AGREEMENTALUMIS INC - ACELYRIN STOCKHOLDERS TO RECEIVE 0.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA46YLXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRN","BK4007","ALMS","BK4139"],"gpt_icon":0},{"id":"2529141872","title":"Alumis Raises Share Consideration for Acelyrin Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2529141872","media":"MT Newswires Live","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529141872?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:17","pubTimestamp":1745234276,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) and Acelyrin (SLRN) said Monday that they agreed on an amended merger deal that reflects an increased share consideration for each Acelyrin share.Under the amended agreement, Acelyrin sh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS","BK4007","SLRN","BK4139"],"gpt_icon":0},{"id":"2529874693","title":"ACELYRIN, INC. Amends Merger Agreement with Alumis","url":"https://stock-news.laohu8.com/highlight/detail?id=2529874693","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529874693?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:57","pubTimestamp":1745233061,"startTime":"0","endTime":"0","summary":"ACELYRIN, INC. ( ($SLRN) ) just unveiled an announcement. On February 6, 2025, ACELYRIN, INC. entered into a merger agreement with Alumis Inc., whi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acelyrin-inc-amends-merger-agreement-with-alumis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acelyrin-inc-amends-merger-agreement-with-alumis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INC","BK4139","SLRN","ALMS","BK4007"],"gpt_icon":0},{"id":"2529879143","title":"Alumis Inc - Expects Runway to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879143?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA46YLXT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","SLRN","BK4007","BK4139"],"gpt_icon":0},{"id":"2529879642","title":"Alumis and ACELYRIN Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879642","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879642?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUAYZMWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ALMS","SLRN"],"gpt_icon":0},{"id":"2529687950","title":"Alumis Inc - ACELYRIN Stockholders to Receive 0.4814 Shares of Alumis per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2529687950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529687950?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUAYZMWC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLRN","ALMS","BK4007"],"gpt_icon":0},{"id":"2529879600","title":"Press Release: Alumis and ACELYRIN Announce Amended Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2529879600","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529879600?lang=en_us&edition=fundamental","pubTime":"2025-04-21 18:30","pubTimestamp":1745231400,"startTime":"0","endTime":"0","summary":"ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis. Merger maximizes the potential value for ACELYRIN stockholders and creates a stronger combined company, best-positioned to realize long-term value of multiple late-stage assets. Bruce Cozadd, Chair of the ACELYRIN Board of Directors and member of the Board Transaction Committee, said, \"Since announcing the merger, we have had extensive conversations with our stockholders who have expressed an understanding of the strategic rationale for this transaction, while also sharing their perspectives on the","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1749614400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2025-06-27","current":-0.522906,"percent":0.956175,"low":-4.913756,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"high":-0.443678,"avg":-2.15659,"sd":1.218803,"marketCap":179538295},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295}],"updateTime":1751277276813}}}